Sienna Biopharmaceuticals Reports Second Quarter 2018 Financial Results
WESTLAKE VILLAGE, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA), a clinical-stage medical dermatology and aesthetics company, today reported the Company’s financial results for the second quarter of 2018. “We are …